SERUM OSTEOPROTEGERIN AND RANKL LEVELS IN CHRONIC ALCOHOLIC LIVER DISEASE
Authors:
- Emilio González-ReimersEGEmilio González-Reimers
- Francisco Santolaria-FernándezFSFrancisco Santolaria-Fernández
- María José DE LA Vega-PrietoMVMaría José DE LA Vega-Prieto
- Antonio Milena-AbrilAMAntonio Milena-Abril
- María José Sánchez-PérezMSMaría José Sánchez-Pérez
- Antonio Martínez-RieraAMAntonio Martínez-Riera
- María DE Los Ángeles Gómez-RodríguezMGMaría DE Los Ángeles Gómez-Rodríguez
Open Access
- 13 February 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Alcohol and Alcoholism
- Vol. 41 (3) , 261-266
Abstract
Objectives: Osteoprotegerin (OPG) is a decoy receptor that binds RANK-ligand (RANKL) and prevents osteoclast activation. Oestrogens, androgens, corticosteroids, parathyroid hormone (PTH), vitamin D, and several cytokines exert their effects on bone modulating the OPG/RANKL system. Since these substances become altered in chronic alcoholic liver disease, we investigated the OPG/RANKL system in alcoholic liver disease, its relation with bone mineral density (BMD) and with several hormones and cytokines. Methods: Serum OPG, RANKL, C-terminal cross-linking telopeptide of type 1 collagen, osteocalcin, insulin-like growth factor 1 (IGF-1), 1,25 dihydroxyvitamin D, IL-6, tumour necrosis factor (TNF)-α, PTH, estradiol, free testosterone and corticosterone were measured in 77 male alcoholic patients, 25 of them cirrhotics. All these patients underwent assessment of BMD at lumbar spine and left hip by a Hologic QDR-2000 (Waltham, MA) bone densitometer. Nineteen non-drinkers male sanitary workers of similar age served as controls. Results: Serum OPG levels were higher in patients (12.66 ± 6.44 pmol/l) than in controls (6.59 ± 1.58 pml/l, P < 0.005), especially in cirrhotics (15.97 ± 7.03 pmol/l) vs non-cirrhotics (10.96 ± 5.45 pmol/l, P < 0.001). Patients also showed higher telopeptide levels (0.60 ± 0.36 vs 0.20 ± 0.10 nmol/100 ml, P < 0.001), less IGF-1 [median = 192, interquartile range (IQR) = 46.7–175.99 ng/ml vs 150, IQR = 118.8–239.4 ng/ml, P < 0.001], vitamin D (25.5, IQR = 18.25–35 pg/ml vs 77.89, IQR = 57.48–98.53 pg/ml, P < 0.001) and osteocalcin (1.8, IQR = 1–3.6 ng/ml vs 6.04, IQR = 4.63–8.20 ng/ml, P < 0.001) than controls, but no differences in PTH and RANKL. Patients also showed lower Z-scores than controls at trochanter (−0.36 ± 1.10 vs 0.26 ± 0.87 in controls, P = 0.026), intertrochantereal area (−0.56 ± 1.16 vs 0.46 ± 1.01, P = 0.001), and total hip (−0.44 ± 1.12 vs 0.42 ± 1, P = 0.003). TNF-α levels were higher in patients (7.40, IQR = 4.30–17.80 pg/ml) than in controls (5.10, IQR = 4.40–8 pg/ml, P = 0.009), especially in cirrhotics (median = 13.90, IR = 6.10–21.10 pg/ml). OPG levels showed strong correlations with TNF-α (rho = 0.57, P < 0.001) and IL-6 (r = 0.62, P < 0.001), but not with BMD. Estradiol levels (31.83 ± 13.11 pg/ml) were higher and free testosterone lower (13.62 ± 11.96 pg/ml) in patients than in controls (20.36 ± 3.08 and 18.19 ± 4.68 pg/ml, respectively, P < 0.001 in both cases). Conclusion: OPG is raised in alcoholics, especially in cirrhotics, showing no relationship with decreased BMD. Also, raised TNF and IL-6 were observed, and were strongly, directly related with OPG levels. Since TNF and IL-6 enhance bone resorption, their relation with OPG suggests a protective effect of raised OPG on bone loss.Keywords
This publication has 39 references indexed in Scilit:
- The RANKL/OPG system and bone mineral density in patients with chronic liver diseaseJournal of Hepatology, 2005
- Osteoprotegerin and RANKL in alcoholic liver cirrhosisLiver International, 2005
- 1α,25 Dihydroxyvitamin D3 Rapidly Regulates the Mouse Osteoprotegerin Gene Through Dual PathwaysJournal of Bone and Mineral Research, 2004
- High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatmentBone, 2004
- Osteoclast differentiation and activationNature, 2003
- High serum osteoprotegerin and low RANKL in primary biliary cirrhosisJournal of Hepatology, 2003
- Moderate Alcohol Consumption Suppresses Bone Turnover in Adult Female RatsJournal of Bone and Mineral Research, 2001
- Skeletal Response to AlcoholAlcohol, Clinical and Experimental Research, 2000
- Interactions between immune and bone cells: new insights with many remaining questionsJournal of Clinical Investigation, 2000
- Ethanol reduces bone formation and may cause osteoporosisThe American Journal of Medicine, 1989